Extract of medicinal plant Artemisia annua interferes with replication of SARS-CoV-2 in vitro

Researchers in the United States have shown that extracts of an aromatic herb called Artemisia annua inhibit the replication of severe acute respiratory coronavirus (SARS-CoV-2) – the agent responsible for the current coronavirus disease 2019 (COVID-19) pandemic.

Bioprospecting for Anti-COVID-19 Interventions From African Medicinal Plants: A Review - Abidemi J. Akindele, Abimbola Sowemimo, Foluso O. Agunbiade, Margaret O. Sofidiya, Olufunsho Awodele, Omobolanle Ade-Ademilua, Ifeoma Orabueze, Ismail O. Ishola

An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment - ScienceDirect

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2, Cell & Bioscience

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

Ethanolic extract of Artemisia campestris subsp. glutinosa (Besser) Batt. inhibits HIV–1 replication in vitro through the activity of terpenes and flavonoids on viral entry and NF–κB pathway - ScienceDirect

In vitro efficacy of artemisinin-based treatments against SARS-CoV-2

In vitro efficacy of Artemisia extracts against SARS-CoV-2, Virology Journal

IJMS, Free Full-Text

Cells, Free Full-Text

Life, Free Full-Text

Frontiers Plant Products as Inhibitors of Coronavirus 3CL Protease